Scarica l'app Stockscreener
1.35
1.46%
-0.02
Dopo l'orario di chiusura:
1.32
-0.03
-2.22%
Precedente Chiudi:
$1.37
Aprire:
$1.35
Volume 24 ore:
71,962
Relative Volume:
0.20
Capitalizzazione di mercato:
$61.73M
Reddito:
$19.94M
Utile/perdita netta:
$-37.37M
Rapporto P/E:
-1.2981
EPS:
-1.04
Flusso di cassa netto:
$-33.38M
1 W Prestazione:
-2.88%
1M Prestazione:
+8.87%
6M Prestazione:
+15.38%
1 anno Prestazione:
-34.15%
Intervallo 1D:
$1.32
$1.37
Intervallo di 1 settimana:
$1.29
$1.40
Portata 52W:
$0.595
$4.18
Werewolf Therapeutics Inc Stock (HOWL) Company Profile
Nome
Werewolf Therapeutics Inc
Settore
Industria
Telefono
617-952-0555
Indirizzo
200 TALCOTT AVENUE, WATERTOWN
Confronta HOWL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HOWL
Werewolf Therapeutics Inc
|
1.35 | 59.45M | 19.94M | -37.37M | -33.38M | -1.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Werewolf Therapeutics Inc Stock (HOWL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-04-03 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-08-24 | Iniziato | Wedbush | Outperform |
| 2023-06-06 | Ripresa | Jefferies | Buy |
| 2021-09-10 | Iniziato | BofA Securities | Buy |
| 2021-05-25 | Iniziato | Evercore ISI | Outperform |
| 2021-05-25 | Iniziato | H.C. Wainwright | Buy |
| 2021-05-25 | Iniziato | Jefferies | Buy |
| 2021-05-25 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Werewolf Therapeutics Inc Borsa (HOWL) Ultime notizie
Volume spikes in Werewolf Therapeutics Inc. stock – what they mean2025 EndofYear Setup & Step-by-Step Swing Trade Plans - Newser
Does Werewolf Therapeutics Inc. fit your quant trading model2025 Year in Review & Stepwise Trade Signal Guides - Newser
Published on: 2025-09-03 06:17:15 - Newser
Published on: 2025-09-03 06:05:26 - Newser
Live market analysis of Werewolf Therapeutics Inc.2025 Analyst Calls & Verified Entry Point Detection - Newser
What Fibonacci levels say about Werewolf Therapeutics Inc. reboundQuarterly Portfolio Review & Fast Gain Stock Tips - Newser
Werewolf Therapeutics to Participate in the Upcoming H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewswire
Werewolf Therapeutics Inc. stock retracement – recovery analysisJuly 2025 Retail & Free Reliable Trade Execution Plans - Newser
Measuring Werewolf Therapeutics Inc.’s beta against major indicesWeekly Profit Recap & AI Driven Price Forecasts - Newser
Sector ETF performance correlation with Werewolf Therapeutics Inc.July 2025 Recap & High Accuracy Investment Entry Signals - Newser
Regression analysis insights on Werewolf Therapeutics Inc. performanceEarnings Performance Report & Real-Time Chart Breakout Alerts - Newser
Applying Wyckoff theory to Werewolf Therapeutics Inc. stock2025 Earnings Impact & Accurate Intraday Trading Signals - Newser
Detecting price anomalies in Werewolf Therapeutics Inc. with AIPortfolio Growth Summary & Stepwise Trade Execution Plans - Newser
What data driven models say about Werewolf Therapeutics Inc.’s futurePortfolio Update Summary & Weekly High Return Stock Opportunities - Newser
Backtesting results for Werewolf Therapeutics Inc. trading strategiesJuly 2025 Drop Watch & Consistent Growth Stock Picks - Newser
Can Werewolf Therapeutics Inc. hit a new high this monthEarnings Performance Report & Weekly Momentum Stock Picks - Newser
Is Werewolf Therapeutics Inc. backed by strong institutional buying2025 Market WrapUp & Fast Gain Swing Trade Alerts - khodrobank.com
Is Werewolf Therapeutics Inc. stock heavily shorted2025 Support & Resistance & Technical Pattern Recognition Alerts - khodrobank.com
Werewolf Therapeutics shares rise 1.54% after-hours after announcing participation in H.C. Wainwright 27th Annual Global Investment Conference. - AInvest
Why Werewolf Therapeutics Inc. stock attracts strong analyst attentionProfit Target & Step-by-Step Trade Execution Guides - Newser
Is now the right time to enter Werewolf Therapeutics Inc.July 2025 Momentum & Stepwise Entry and Exit Trade Signals - khodrobank.com
Werewolf Therapeutics announces fireside chat at H.C. Wainwright conference. - AInvest
Leading Cancer Immunotherapy Developer Werewolf Therapeutics Featured at Global Investment Conference - Stock Titan
Full technical analysis of Werewolf Therapeutics Inc. stockMarket Risk Report & Daily Growth Stock Tips - Newser
Momentum divergence signals in Werewolf Therapeutics Inc. chartMarket Growth Summary & Real-Time Chart Breakout Alerts - Newser
Werewolf Therapeutics’s SWOT analysis: innovative platform drives stock potential - Investing.com
Statistical indicators supporting Werewolf Therapeutics Inc.’s strengthBond Market & Real-Time Stock Entry Alerts - Newser
Is Werewolf Therapeutics Inc. stock poised for growth2025 Market WrapUp & Fast Momentum Stock Entry Tips - Newser
Will Werewolf Therapeutics Inc. stock benefit from AI tech trendsBull Run & Daily Stock Momentum Reports - Newser
Custom watchlist performance reports with Werewolf Therapeutics Inc.July 2025 Update & AI Driven Price Predictions - Newser
What to do if you’re stuck in Werewolf Therapeutics Inc.July 2025 Catalysts & Community Consensus Stock Picks - Newser
Werewolf Therapeutics Inc. stock outlook for YEARTrade Risk Assessment & Daily Technical Forecast Reports - Newser
Is it time to cut losses on Werewolf Therapeutics Inc.2025 Valuation Update & Safe Capital Growth Stock Tips - Newser
What momentum shifts mean for Werewolf Therapeutics Inc.July 2025 Decliners & Daily Entry Point Alerts - Newser
When is the best time to exit Werewolf Therapeutics Inc.Chart Signals & High Conviction Buy Zone Picks - Newser
Published on: 2025-08-31 01:19:46 - Newser
Werewolf Therapeutics Inc Azioni (HOWL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Werewolf Therapeutics Inc Azioni (HOWL) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Director |
May 14 '25 |
Buy |
0.98 |
162,539 |
159,288 |
6,237,482 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
May 13 '25 |
Buy |
0.98 |
52,974 |
51,915 |
6,074,943 |
| MPM BioVentures 2014, L.P. | 10% Owner |
Mar 27 '25 |
Sale |
1.05 |
1,963 |
2,061 |
3,208,793 |
| EVNIN LUKE | Director |
Mar 27 '25 |
Sale |
1.05 |
2,425 |
2,546 |
4,309,860 |
| GADICKE ANSBERT | 10% Owner |
Mar 27 '25 |
Sale |
1.05 |
4,386 |
4,605 |
6,718,670 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):